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Abstract
The translation of in vitro findings to clinical outcomes is often elusive. Trauma/hemorrhagic shock (T/HS) results in hepatic
hypoxia that drives inflammation. We hypothesize that in silico methods would help bridge in vitro hepatocyte data and
clinical T/HS, in which the liver is a primary site of inflammation. Primary mouse hepatocytes were cultured under hypoxia
(1% O2) or normoxia (21% O2) for 1–72 h, and both the cell supernatants and protein lysates were assayed for 18
inflammatory mediators by LuminexTM technology. Statistical analysis and data-driven modeling were employed to
characterize the main components of the cellular response. Statistical analyses, hierarchical and k-means clustering, Principal
Component Analysis, and Dynamic Network Analysis suggested MCP-1/CCL2 and IL-1a as central coordinators of
hepatocyte-mediated inflammation in C57BL/6 mouse hepatocytes. Hepatocytes from MCP-1-null mice had altered dynamic
inflammatory networks. Circulating MCP-1 levels segregated human T/HS survivors from non-survivors. Furthermore, T/HS
survivors with elevated early levels of plasma MCP-1 post-injury had longer total lengths of stay, longer intensive care unit
lengths of stay, and prolonged requirement for mechanical ventilation vs. those with low plasma MCP-1. This study
identifies MCP-1 as a main driver of the response of hepatocytes in vitro and as a biomarker for clinical outcomes in T/HS,
and suggests an experimental and computational framework for discovery of novel clinical biomarkers in inflammatory
diseases.
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Introduction
Among many other functions, the liver plays a critical role in
inflammation and innate immunity, processes that are controlled
by multiple cell types including hepatocytes, Kupffer cells, and
other non-parenchymal cells. Although at least 15 different cell
types can be found in normal liver [1], hepatocytes constitute the
largest pool of parenchymal cells, comprising approximately 60–
80% of the total liver cells [1,2]. Inflammatory conditions such as
ischemia/reperfusion (I/R) and post-trauma hemorrhagic shock
(T/HS) are associated with liver hypoxia [3,4]. It is now accepted
that hypoxia is not merely an outcome of the inflammatory
response, but rather is a key driver of the development of
inflammation through the regulation of O2-dependent signal
transduction and gene expression [5,6].
Mathematical and computational (in silico) methods have
emerged as adjuncts to in vitro and in vivo studies of acute
inflammation [7]. For example, we have recently applied both
mechanistic and data-driven computational modeling to help
define the dynamic, multi-dimensional inflammatory response
to T/HS in vivo [8–12]. The goal of the present study was to
determine if combined in vitro/in silico studies could help
elucidate key hepatic inflammatory mediators relevant to
human T/HS. This study identifies the chemokine Monocyte
Chemoattractant Protein-1 (MCP-1/CCL2) as a main driver of
the response of hepatocytes in vitro and as a biomarker for organ
damage in clinical settings of T/HS, and, more generally,
suggests a pathway for combined experimental and computa-
tional studies to facilitate the discovery of novel clinical
biomarkers of inflammation.
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Results
MCP-1 is a central component of the dynamic, multi-
dimensional response of hepatocytes to cell stress
To assess the response of hepatocytes to hypoxia, primary wild-
type mouse hepatocytes were subjected to 1% O2 for 1–72 h, and
18 mouse cytokines were measured in both the supernatant and
whole-cell lysate. Hepatocytes cultured under normoxic (21% O2)
conditions served as controls. One-way ANOVA showed that, in
normoxic hepatocytes, MCP-1, KC, and IP-10 (in lysates) and
MCP-1, KC, and MIG (in supernatants) were altered significantly
(Table 1). In hypoxic hepatocytes, the significantly altered
mediators were MCP-1, MIG, IL-1a, IL-1b, IL-10, and IL-13
(in lysates) and MCP-1, IP-10, IL-1a, and VEGF (in supernatants).
Thus, MCP-1 was the only mediator that exhibited significant
changes in all four conditions examined, as shown in Fig. 1A.
Hierarchical Clustering and Principal Component Analysis
reveal key differences in inflammatory mediator
production/release in the hepatocyte response to cell
stress
In order to address the question of which groups of mediators
exhibit similar dynamics in normoxic and hypoxic hepatocytes, we
performed hierarchical clustering on fold changes for each
mediator at each pair of consecutive time points. We examined
both raw values and fold change values for all mediators over each
time interval. Each inflammatory mediator’s values over time
made up its dynamic pattern of expression and release. To identify
those inflammatory mediators that showed similar production or
secretion behavior, these patterns were then compared and
grouped using hierarchical clustering, with inflammatory media-
tors in the resulting dendrogram ordered according to their
membership in the clusters that emerged (Fig. 1B).
We also sought to determine the subset of mediators that evolve
dynamically in a manner that is most characteristic of the response
to normoxia or hypoxia, respectively. Inflammatory mediators that
have similar patterns of covariance have similar loadings onto
principal components, and so would be expected to project in a
similar direction in principal component space. We therefore used
the angle of an inflammatory mediator’s projection into principal
component space as the basis of a distance metric in k-means
clustering (Figures S1, S2, S3, S4). This analysis suggested that,
despite an overlap in common mediators, k-means clustering could
differentiate normoxia from hypoxia and lysates from superna-
tants. Furthermore, MCP-1 and KC were generally grouped
together and were the predominant mediators along the first
principal component.
A predominant role for MCP-1, KC, and IL-1a in the
hepatocyte response to stress inferred from Dynamic
Network Analysis
We sought to determine the consensus of the three aforemen-
tioned, independent clustering experiments. If the cluster mem-
berships were similar, then those mediators that did not segregate
consistently across different clusterings could be treated as noise.
In contrast, those inflammatory mediators that consistently
segregated together were considered as mediators exhibiting
similar or correlated dynamic trajectories. We first calculated an
Adjusted Rand Index (ARI) [13–16] to quantify the degree to
which any two clustering results were in agreement. This
comparison (see Figures S9, S10, S11, S12) resulted in a
‘‘consensus clustering’’ showing the inflammatory mediators that
exhibited the same segregation pattern across all analysis methods,
suggesting that MCP-1 and KC segregate together across all
experimental conditions (Fig. 1C).
This meta-clustering analysis suggested groups of inflammatory
mediators with similar dynamic patterns. We next performed
Dynamic Network Analysis (DyNA) [12] to suggest mediators that
appear to be ‘‘hubs’’ (or most connected to other mediators).
(Figs. 2A–B; Figure S17). The total number of dynamic network
connections is shown in Fig. 2C. Based on DyNA, MCP-1 and
KC were the most connected mediators across all time points in
normoxia supernatants, and at 24–72 h in normoxia lysates
(Fig. 2A). In hypoxia, the most connected inflammatory mediators
were IL-1a and VEGF in supernatants and IL-1a and MIP-1a in
lysates (Fig. 2B). Overall, the most connected inflammatory
mediators were MCP-1 and IL-1a, with MCP-1 being the only
highly-connected node present in all experimental conditions
examined (Fig. 2C).
Inflammatory dynamics and networks are disrupted in
MCP-12/2 hepatocytes
Hypothesizing a central role for MCP-1 in the response of
mouse hepatocytes to cell stress based on the above analyses, we
repeated these experiments using hepatocytes from MCP-12/2
mice. We first sought to verify that MCP-1 was absent in MCP-
12/2 mice. As shown in Fig. 3A, normoxic hepatocytes from
MCP-12/2 mice did not express MCP-1 by Western blot, while a
weaker band of approx. 30 kDa was detected in the lysates from
hypoxic cells. In contrast, MCP-1 protein expression was
significantly higher in cell lysates of both normoxic and hypoxic
hepatocytes from wild-type mice at 48 and 72 h (Fig. 3A). This
Table 1. Significance levels (P,0.05) for production and
release of inflammatory mediators from wild-type mouse
hepatocytes cultured under normoxic or hypoxic conditions
(1–72 h) as determined by one-way ANOVA.
Normoxia Hypoxiaa
Lysate Supernatant Lysate Supernatant
GM-CSF 0.721 1.0 0.753 0.086
IFN-c 0.105 1.0 0.452 1.0
IL-1a 0.591 1.0 0.023 0.007
IL-1b 0.559 0.664 0.026 0.886
IL-2 0.126 0.929 0.240 0.919
IL-4 0.901 0.942 0.935 0.656
IL-5 1.0 1.0 0.123 0.101
IL-6 0.091 0.914 0.223 0.059
IL-10 0.346 0.947 0.035 0.832
IL-13 0.601 1.0 0.002 0.650
IL-17 0.980 0.921 0.958 0.999
IP-10 0.045 0.513 0.135 0.046
KC 0.002 ,0.001 0.374 0.283
MCP-1 0.001 ,0.001 0.003 ,0.001
MIG 0.150 0.002 0.016 0.177
MIP-1a 0.636 0.416 0.081 0.543
TNF-a 0.987 0.685 0.056 0.999
VEGF 0.271 ,0.001 0.073 ,0.001
aFor hypoxia time courses, the analysis was performed using as baseline the
respective concentration values for normoxia at 1 h.
doi:10.1371/journal.pone.0079804.t001
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analysis suggested the low, but detectable, presence of a protein
with MCP-1-like characteristics in the nominally MCP-12/2mice.
One-way ANOVA (Table 2) suggested that, in normoxic
MCP-12/2 hepatocytes, only MIG, KC, and IL-6 (in lysates)
and KC, IL-1b, and VEGF (in supernatants) were altered
significantly. In hypoxic MCP-12/2 hepatocytes, MIP-1a, IL-
1a, IL-1b, IL-2, IL-6, IL-10, IL-13, IFN-c, and TNF-a (in
lysates) and KC, IL-1a, and VEGF (in supernatants) were
altered significantly. Hierarchical clustering defined different
networks and modules of mediators in MCP-12/2 hepatocytes
(Fig. 3B) as compared to wild type cells (Fig. 1B). Meta-
clustering (Figures S5, S6, S7, S8) suggested that IL-1b and
MCP-1 clustered together across all 4 experimental conditions
in MCP-12/2 hepatocytes (Fig. 3C).
Dynamic Network Analysis suggests altered networks of
inflammatory mediators in MCP-12/2 hepatocytes
We next carried out DyNA of lysates and supernatants from
normoxic and hypoxic MCP-12/2 hepatocytes (Figs. 4A–C;
Figure S18). This analysis suggested a significant decrease in the
number of connections (Figs. 4A–B) in both lysates and
supernatants of normoxic cells, and in hypoxia supernatants, as
compared to wild-type hepatocytes (see Figs. 2A–B). In superna-
tants of normoxic MCP-12/2 hepatocytes, KC was the most
significantly changed mediator (though with nearly zero connec-
tions across all time points; Fig. 4A), whereas in supernatants of
hypoxic MCP-12/2 hepatocytes this chemokine was a central
node with one connection only at 24–72 h (Fig. 4B). In lysates
from normoxic MCP-12/2 hepatocytes, IL-6 was the most
significantly changed mediator, but with zero connections
(Fig. 4A). However, this cytokine was the most connected
mediator (along with IFN-c) in hypoxia lysates at all-time intervals
after 6 h (Fig. 4B). DyNA suggested a clear reduction in the total
number of dynamic connections among inflammatory mediators
in MCP-12/2 cells, with IL-6 being the most connected mediator
(but only in hypoxia lysates; Fig. 4C).
IL-6 expression and release is reduced in MCP-12/2
hepatocytes
Because one-way ANOVA and DyNA revealed that the most
significant changes in inflammatory mediator production and
release were observed for MCP-1 and IL-6, we hypothesized that
MCP-1 would affect IL-6 expression and release in stressed
hepatocytes. IL-6 levels were significantly lower in both normoxia
lysates and supernatants of MCP-12/2 hepatocytes as compared
to normoxic (Fig. 5A–B) and hypoxic (Fig. 5C–D) wild-type
controls. These results suggest that the differential expression and
release of IL-6 in mouse hepatocytes depends, at least in part, on
MCP-1.
In situ hepatocyte expression of MCP-1 and IL-6 is
attenuated in MCP-12/2 cells
The differential expression of MCP-1 and IL-6 in both wild-
type and MCP-12/2 cells was confirmed using confocal immu-
nofluorescence (Fig. 6A). Quantitative analysis of the images
(Fig. 6B) revealed that MCP-1 is indeed elevated in wild-type
hepatocytes as compared to MCP-12/2 cells, with much higher
levels in normoxia vs. hypoxia, confirming the results obtained by
Luminex measurements (see Fig. 1A). Similarly, cellular IL-6
levels were lower in the MCP-12/2 cells as compared to wild-type
hepatocytes, especially under hypoxic conditions (Fig. 6B).
Elevated plasma MCP-1 levels as biomarker for mortality
and morbidity in human trauma/hemorrhage
Given the central role of the liver in the in vivo response to T/HS
[17], we hypothesized that plasma MCP-1 levels would serve as an
indicator of mortality in human T/HS. Indeed, an analysis of a
cohort of 30 trauma patients revealed that patients could be
segregated between survivors and non-survivors based on plasma
MCP-1 levels within the first 24 h (Fig. 7A). Similar segregation
could be made using plasma IL-6 levels for the same groups of
patients: survivors (193.4636.7 pg/ml) vs. non survivors
(1050.16522.9 pg/ml) (P,0.001, analyzed by Mann-Whitney U
test).
MCP-1 also appeared to coordinate stress-induced production
of mediators including IL-6 (see above), and IL-6 has been
identified consistently as a marker of negative outcomes in T/HS
[18,19]. Accordingly, we next evaluated the potential of plasma
MCP-1 levels as a biomarker for morbidity in a separate cohort of
survivors of blunt trauma. A cohort of 31 hypotensive patients was
matched with 31 normotensive patients (all survivors). Plotting IL-
6 vs. MCP-1 plasma concentrations for the trauma patient cohort
as a whole (n = 62) suggested that circulating IL-6 levels in these
patients could be segregated into two groups based on circulating
MCP-1 levels: low MCP-1 (,1000 pg/ml) and high MCP-1
(.1500 pg/ml, Figs. 7B–C). Furthermore, analysis of the data
showed a positive correlation between MCP-1 and IL-6 in both
normotensive (Pearson Product Moment correlation coeffi-
cient = 0.59, Fig. 7B) and hypotensive (0.41, Fig. 7C) blunt
trauma patients. The P values associated with these correlation
coefficients were highly significant (5.16610217 and 0.000047 for
normotensive and hypotensive blunt trauma patients, respectively).
We then performed a different grouping irrespective of blood
pressure status, based solely on MCP-1 concentrations
(,1000 pg/ml vs. .1500 pg/ml). This grouping reduced the
study cohort to 46 T/HS patients. T/HS patients with lower
circulating MCP-1 levels (Fig. 7D; 400.54615.75 pg/ml; range:
12.13–991.67 pg/ml [n = 38;]) have lower circulating IL-6 levels
(106.1468.07 pg/ml; range: 3.42–682.11 pg/ml [n= 38]) as
compared to patients with higher circulating MCP-1 (Fig. 7E;
Figure 1. Inflammatory mediator production by primary mouse hepatocytes and meta-clustering analysis. Freshly isolated
hepatocytes from C57BL/6 (wild-type) mice were cultured under normoxic (control, 21% O2, open symbols) or hypoxic (1% O2, closed symbols)
conditions for 1–72 h as described in the Materials and Methods. Both lysates and supernatants were assayed for 18 mouse inflammatory mediators
using the Luminex xMAP technology and the measurements were normalized for protein content as indicated. (A) MCP-1 expression and release in
primary mouse hepatocytes (mean 6 SEM, n = 4–8 independent experiments, analyzed by Two-Way ANOVA followed by the Holm-Sidak post-hoc
test, *P,0.001, normoxia vs. hypoxia within a specific time point). The insets show the levels of MCP-1 in hypoxia samples. (B) Hierarchical clustering
over fold changes in wild-type hepatocytes (normoxia vs. hypoxia): Fold change values for each inflammatory mediator are represented in heat maps,
ranging from large negative (green) to large positive values (red). No changes (zero values) changes are represented in black (see Materials and
Methods). (C) Comparison between meta-clustering analysis outcomes in normoxia and hypoxia (see Materials and Methods). The shading of the
boxes indicates the grouping of mediators that exhibited the same segregation pattern across all methods. For each experimental condition (NL, HL,
NS and HS), only the mediators appearing in each consensus are shown. For comparison between experimental conditions only mediators common
to both consensuses are shown. The consensus clusters characterize the cellular response and were derived from hierarchical clustering (mediators
with similar dynamic trajectories) and from PCA (mediators with the strongest covariance with other mediators).
doi:10.1371/journal.pone.0079804.g001
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4098.716772.85 pg/ml; range: 1486.46–26112.26 pg/ml [n = 8])
who exhibited higher, though more variable circulating IL-6 levels
(1457.676391.23 pg/ml; range: 26.12–10582.37 pg/ml [n = 8]).
Patients with higher circulating MCP-1 levels had worse
outcomes, as indicated by a longer total length of stay (LOS),
longer intensive care unit (ICU) LOS, and greater requirement for
mechanical ventilation (Fig. 7F). Interestingly, statistical analysis
using two-way ANOVA showed no significant differences between
MCP-1 levels in the initial cohort of normotensive vs. hypotensive
patients (n = 31 each, Figs. 8A–B), and analysis of the clinical
outcomes of the patients segregated based on their normotensive/
hypotensive status revealed no differences between normotensive
(n = 27) and hypotensive patients (n = 19) (Fig. 8C).
Discussion
Liver ischemia and subsequent reperfusion, which can occur in
T/HS and resuscitation, lead to inflammatory liver injury as well
as to the systemic elaboration of inflammatory mediators and
subsequent multiple organ dysfunction [17,20,21]. Liver hypoxia
is a primary feature of HS in experimental models [3,4]. Hypoxic
stress, however, is but one of a variety of stresses (e.g. endoplasmic
reticulum stress and autophagy) encountered by hepatocytes in
settings such as T/HS [22] and I/R [23]. We therefore reasoned
that the analysis of synthesis and secretion of inflammatory
mediators by stressed hepatocytes would help in our understand-
ing of the pathophysiology of T/HS and other conditions
characterized, at least in part, by hepatic stress.
Our key finding is that a combined in vitro/in silico analysis of the
dynamics of synthesis and secretion of multiple inflammatory
mediators points to the chemokine MCP-1 as a central coordina-
tor of the inflammatory response of stressed hepatocytes. Pursuing
this in vitro/in silico-derived hypothesis allowed us to segregate blunt
trauma patients based on circulating levels of MCP-1. Important-
ly, this segregation of patients would have proven ineffective if
performed based solely on the patients’ normotensive/hypotensive
status post-injury.
Chemokines are small cytokine-like, heparin-binding molecules
help orchestrate immune and stem cell infiltration into the liver in
response to both acute and chronic injuries [20,24]. Hepatic
chemokines are released during inflammatory injury (infection,
drug intoxication), and play a key role in the activation and
proliferation of liver-resident cells (including hepatocytes, stellate
cells, and endothelial cells). In our studies, multiple chemokines
were synthesized with diverse time courses by stressed hepatocytes.
Though chemokines are often thought to be highly redundant in
their actions, MCP-1 was the only mediator that exhibited
significant changes in both normoxia and hypoxia, and in both cell
lysates (denoting cellular expression) and supernatants (denoting
secretion by cells). Our findings of perturbed dynamic inflamma-
tory networks in MCP-12/2 mice supports the hypothesis that this
chemokine plays a central, driving role in the hepatocyte response
to stress. The apparently incomplete elimination of MCP-1 (or
presence of a protein highly-homologous to MCP-1) in MCP-12/2
cells raises the possibility that the actual effects of MCP-1 on
coordinating inflammation might be even more pronounced than
those we observed in these studies.
MCP-1 (CCL2) was first identified as a monocyte-specific
chemoattractant, and was later shown to attract memory T
lymphocytes and NK cells. Binding to its seven-transmembrane G-
protein-coupled receptor CCR2 (CC chemokine receptor 2)
results in signaling events that lead to the recruitment of
monocytes in a variety of in vivo experimental models of infection
and injury [25,26]. In addition to recruiting monocytes, MCP-1
can also activate macrophages and endothelial cells and has been
implicated in the attraction of neutrophils and the generation of
neutrophil-dependent tissue damage [26]. Lu et al. showed that
despite normal numbers of circulating leukocytes and resident
macrophages, MCP-12/2 mice were specifically unable to recruit
monocytes 72 h after intraperitoneal thioglycollate administration,
indicating that MCP-1 is essential for monocyte recruitment and
the expression of cytokines related to T helper responses in vivo
[27].
MCP-1 can be upregulated in the liver in vivo by I/R [28] as well
as by bacterial endotoxin [29], and in isolated mouse hepatocytes
by hypoxia [30] and the present study). The expression of MCP-1
in normoxic, primary cultured hepatocytes was thought to be due
to the stress of cell isolation [31], and we likewise found elevated
MCP-1 in normoxic hepatocytes. The effects of MCP-1 in the liver
range from protective (e.g. in experimental acetaminophen-
induced injury) to detrimental (e.g. during experimental I/R
injury) [30].
In addition to MCP-1, our studies suggest that IL-1a, IL-6, KC,
and MIG exhibit the most significant dynamic changes in stressed
hepatocytes. Our results suggest that MCP-1 regulates the
production of these other inflammatory mediators. This hypothesis
is supported by prior studies, in which the expression of hepatic
pro-inflammatory cytokines (including IL-6 and KC) was induced
in alcohol-fed wild-type, but inhibited in MCP-12/2 animals [32].
In support of this central role for KC, Frink et al showed that
neutralization of this chemokine ameliorated liver damage after
T/HS in mice. These authors also showed that MCP-1 causes
organ damage via upregulation of KC, supporting our findings of
a network of hepatic inflammation that involves these two
chemokines. However, the exact source of KC remained unknown
[33]; our present study suggests that hepatocytes are a key source
of this chemokine.
Multiple studies have shown that IL-6 is a biomarker for adverse
outcomes in settings such as trauma/hemorrhage and sepsis and
specifically of poor outcome in trauma [18,19]. This was reflected
in our own clinical cohort, since we could segregate survivors from
non-survivors based on plasma IL-6 levels. Importantly, our
studies suggest that IL-6 is highly correlated with MCP-1 in T/HS
patients, and that the production of IL-6 by hypoxic hepatocytes
was essentially abolished in the absence of endogenous MCP-1.
Taken together, our studies suggest that MCP-1 drives IL-6
production by hepatocytes. Interestingly, a recent study suggests
the presence of a positive feedback loop involving IL-6 and MCP-1
in a setting of vascular inflammation [34].
The use of applied mathematical models and algorithms
constitute a novel tool for interpreting complex biological data.
Figure 2. Dynamic Network Analysis (DyNA) of inflammatory mediators produced by normoxic and hypoxic mouse hepatocytes.
Primary hepatocytes from wild-type mice were cultured under normoxic or hypoxic conditions (1–72 h) followed by measurement of inflammatory
mediators in both lysates and supernatants and lysates as described in the Materials and Methods. After data normalization, DyNA during each of the
following five time frames: 1–3 h, 3–6 h, 6–24 h, 24–48 h, and 48–72 h was performed for both lysates and supernatants as indicated. Panels show a
summary of the DyNAs representing the most connected inflammatory mediator ‘‘nodes’’ for both normoxia (A) and hypoxia (B) lysates and
supernatants. Each mediator’s node size is proportional to the number of connections it has in a given time interval. (C) Stacked bars representing
the total number of connections for each inflammatory mediator over all time intervals.
doi:10.1371/journal.pone.0079804.g002
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In 2005, a pioneering study in this field reported on a systems
model comprising a large number of intracellular signaling events
directly linked to outputs associated with apoptosis, created in
order to study how molecular information is processed as a
network [35]. Prior studies have also utilized advanced compu-
tational analyses to discern key features of the inflammatory
biology of hepatocytes. For example, Alexopoulos et al studied
26,000 protein state measurements from isolated primary human
hepatocytes and HepG2 liver cancer cells exposed to growth
factors or inflammatory mediators, yielding interaction graphs
using multilinear regression [36]. The authors suggested major
differences between primary and transformed hepatocytes with
respect to Toll-like receptor-4 signaling and NF-kB-dependent
secretion of chemokines and cytokines, and suggested, as we do
here, that combined in vitro/in silico analyses can yield novel
insights into hepatocyte biology [36]. More recently, Boolean logic
models of immediate-early signaling in liver cells were created by
training a literature-based prior knowledge network against
biochemical data obtained from primary human hepatocytes as
well as four hepatocellular carcinoma cell lines exposed to
combinations of cytokines and small-molecule kinase inhibitors
[37]. Our present study extends this paradigm to define key nodes
in the stress-induced inflammatory networks induced in hepato-
cytes, as well as suggesting higher-order, clinically-applicable
insights. Indeed, this study points to various similarities between
hepatocytes in vitro and T/HS in vivo. For example, as in the
present study, we found that, together with MIG, IL-6 was highly
elevated but disconnected from other inflammatory mediators
comprising a dynamic network of inflammation induced by
experimental T/HS in mice [12]. Our present study raises the
possibility that MCP-1 is the stimulus for post-HS MIG and IL-6.
In the present study, we developed a novel algorithm for
consensus clustering of multiple data-driven analyses of dynamic
responses. We hypothesized that those inflammatory mediators
exhibiting the most coordination across experimental conditions
could be important drivers or indicators of that process. The
strategy we employed was to extract patterns from dynamic data,
and to assess the measure of similarity across multiple dynamic
patterns. To distill the most important information from three
independent clustering results over 18 mediators for each of 4
experimental conditions, we filtered the results by discarding
inflammatory mediators that showed inconsistent segregation
patterns across the three analyses. A consensus clustering
containing only the mediators whose coordination patterns in
which we could be most confident was the basis of comparison
across experimental conditions. This method identified MCP-1 as
the most relevant mediator in our studies.
This novel approach to data-driven modeling helped formulate
a key hypothesis of our study, namely that circulating levels of
MCP-1 could serve as a biomarker for mortality in human
trauma/hemorrhage, and that the outcomes of trauma survivors
would differ in high- vs. low-producers of MCP-1. Importantly,
our results suggest that circulating levels of MCP-1 are better
discriminators of outcome in our moderately-injured blunt trauma
survivors than hypotension. This, despite the fact that even a brief
period of hypotension was suggested to elevate post-trauma
morbidity and mortality in injured patients [38]. Collectively,
our results provide a systems view of the hepatocyte inflammatory
response to cell stress, with implications for ischemia and
hemorrhage, and point to hepatocytes as a likely cellular source
of cytokines/chemokines in the inflammatory response. Further-
more, these results highlight the capacity of data-driven analyses
for suggesting novel, clinically-relevant targets.
Materials and Methods
Mouse hepatocyte isolation and culture
All procedures involving animals were approved by the Animal
Care and Use Committee of the University of Pittsburgh.
Figure 3. MCP-1 is a central component of the dynamic, multi-dimensional response of hepatocytes to cell stress. Primary hepatocytes
from wild-type and MCP-12/2 mice were cultured under normoxic (N) or hypoxic (H) conditions for 1–72 h, followed by LuminexTM analysis of 18
inflammatory mediators in both the supernatant (SN) and whole-cell lysate (L). The measurements were normalized and hierarchical and k-means
clustering was performed as described in the Materials and Methods. (A) A representative Western blot showing MCP-1 protein expression in cell
lysates from normoxic (N) and hypoxic (H) MCP-12/2 and wild-type mouse hepatocytes (48 and 72 h) and densitometric analysis as described in the
Materials and Methods. (B) Hierarchical clustering over fold changes in MCP-12/2 hepatocytes (normoxia vs. hypoxia): Fold change values for each
inflammatory mediator ranging from large negative (green) to large positive values (red) are shown. No fold changes (zero values) are represented in
black. (C) Comparison between meta-clustering analysis outcomes in normoxia and hypoxia (see Materials and Methods). The shading of the boxes
indicates the grouping of mediators that exhibited the same segregation pattern across all methods. For each experimental condition (NL, HL, NS and
HS), only the mediators appearing in each consensus are shown. For comparison between experimental conditions only mediators common to both
consensuses are shown.
doi:10.1371/journal.pone.0079804.g003
Table 2. Significance levels (P,0.05) for production and
release of inflammatory mediators from MCP-12/2 mouse
hepatocytes cultured under normoxic or hypoxic conditions
(1–72 h) as determined by one-way ANOVA.
Normoxia Hypoxiaa
Lysate Supernatant Lysate Supernatant
GM-CSF 0.918 0.535 0.239 0.423
IFN-c 0.897 0.371 ,0.001 0.530
IL-1a 0.869 0.249 0.002 0.034
IL-1b 0.748 0.031 0.008 0.369
IL-2 0.978 0.332 0.006 0.282
IL-4 0.982 0.669 0.978 0.054
IL-5 0.757 1.0 0.379 1.0
IL-6 ,0.001 0.475 ,0.001 0.403
IL-10 0.439 0.696 ,0.001 0.570
IL-13 0.191 0.888 ,0.001 0.978
IL-17 0.992 0.995 0.960 0.945
IP-10 0.783 0.572 0.925 0.518
KC ,0.001 ,0.001 0.234 0.009
MCP-1 0.823 0.535 0.573 0.782
MIG 0.003 0.761 0.609 0.068
MIP-1a 0.363 0.078 0.009 0.653
TNF-a 0.833 1.0 0.002 1.0
VEGF 0.599 ,0.001 0.242 0.019
aFor hypoxia time courses, the analysis was performed using as baseline the
respective concentration values for normoxia at 1 h.
doi:10.1371/journal.pone.0079804.t002
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Hepatocytes were harvested from wild-type C57BL/6 mice (n = 8
animals from Charles River Laboratories, Wilmington, MA) or
MCP-1/CCL2-null (MCP-12/2) mice (n = 4 animals from The
Jackson Laboratory, Bar Harbor, ME) [27] and plated as
previously described [39]. After overnight incubation, the medium
was removed and cells were further incubated with fresh media
containing 5% heat-inactivated calf serum. Hypoxic conditions
were obtained by placing the cells into a modular incubator
chamber (Billups-Rothenburg, Del Mar, CA) flushed with a
hypoxic gas mixture containing 1% O2, 5% CO2 and 94% N2.
Normoxic hepatocytes served as control.
Protein isolation, sample preparation and Western blot
analysis
At the end of each experiment, the supernatants were stored at
220uC until further analysis and the cell monolayers were washed
twice with ice-cold PBS and resuspended in ice-cold lysis buffer
(Cell Lysis Buffer 106 from Cell Signaling Technology, Danvers,
MA) containing the protease inhibitors leupeptin (0.1 mg/ml) and
phenylmethylsulfonyl fluoride (1 mM) followed by total protein
isolation as previously described [39]. Protein samples (50 mg) were
separated on 15% SDS-polyacrylamide gels followed by electro-
blotting onto PVDF nitrocellulose membranes. Immunodetection
of MCP-1 was done using a mouse specific rabbit polyclonal anti-
MCP-1 antibody (Cell Signaling, Danvers, MA) at 1:1000 dilution,
and the immunoreactive bands were visualized after incubation
with the SuperSignal West Dura Extended Duration Substrate
mouse kit (Thermo Scientific, Rockford, IL). For normalization,
the membranes were stripped and re-probed with an anti-b-actin
antibody from Abcam (Cambridge, MA).
Measurement of inflammatory mediators
Mouse inflammatory mediators were detected in both cell
lysates and supernatants using the MilliplexTM Mouse Cytokine/
Chemokine Panel I beadset (Millipore, Billerica, MA) and the
LuminexTM 100 IS system (Luminex, Austin, TX) as per
manufacturer’s specifications. The antibody bead kit included:
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF),
Interferon-c (IFN-c), Interleukin (IL)-1a, IL-1b, IL-2, IL-4, IL-
5, IL-6, IL-10, IL-13, IL-17, Interferon-c-inducible Protein 10
(IP-10/CXCL10), Keratinocyte-derived Cytokine (KC/
CXCL1), Monocyte Chemoattractant Protein-1 (MCP-1/
CCL2), Monokine induced by Interferon-c (MIG/CXCL9),
Macrophage Inflammatory Protein-1a (MIP-1a/CCL3), Tumor
Necrosis Factor-a (TNF-a), and Vascular Endothelial Growth
Factor (VEGF).
Immunocytochemistry
Freshly isolated mouse hepatocytes (wild-type and MCP-12/2)
plated on coverslips (26105 cells/22-mm glass coverslip, BD
Biocoat, Bedford, MA) were cultured under normoxic (control) or
hypoxic (1% O2) conditions for 48 h. Cells were then fixed and
visualized as described previously [40]. For immunostaining the
following primary and secondary antibodies (diluted in PBS
containing 1% donkey serum) were used: LEAFTM Purified anti-
mouse MCP-1 antibody (1:2000; Cat. No. 505905, BioLegend,
San Diego, CA), rabbit polyclonal anti-IL-6 antibody (1:2000; Cat.
No. ab6672, Abcam), Cy3-conjugated anti-mouse (1:1000; Cat.
No. 715-165-151, Jackson-ImmunoResearch Laboratories, West
Grove, PA), Alexa Fluor-conjugated 647 anti-rabbit (1:1000; Cat.
No. A31573, Invitrogen, Grand Island, NY), and 488-conjugated
anti-phalloidin (1:1000; Cat. No. A12379, Invitrogen). For nuclei
detection the slides were counterstained with Hoechst 33342
(1:3000) for 5 min at room temperature followed by 3 washes in
PBS for 10 min.
Statistical analysis and data-driven modeling
Before the statistical analyses and in order to account for
experimental variability in cell number and protein concentration
between individual experiments, the final mediator concentrations
adjusted for protein content (CF) were obtained from the Luminex
analysis for each individual mediator measurement (C) and its
respective lysate protein concentration (as determined by BCA, see
above) using the following formulas:
For cell supernatants CF~
C pg=mlð Þ|VSN mlð Þ
 
BCA mg protein=mlð Þ
 
|
VL mlð Þ

|1000;
and for cell lysates CF~
C pg=mlð Þ

BCA mg protein=mlð Þ
 
|
1000:
The final mediator concentrations (CF) are thus expressed in pg/
mg total protein, where the supernatant volume (VSN) and lysis
buffer volume (VL) values used were as follows: 60 mm Petri dish
(36106 cells, VSN= 3 ml, VL= 200 ml) and 100 mm Petri dish
(56106 cells, VSN= 5 ml, VL= 400 ml).
Experimental data are presented as mean 6 SEM. Analysis was
performed by t- test, One-way or Two-way Analysis of Variance
(ANOVA) followed by the Holm-Sidak post-hoc test as indicated.
Significance of differences in clinical outcomes was determined by
Mann-Whitney U test using SigmaPlot (Systat Software, San Jose,
CA).
Before any dynamic analysis, the final mediator concentrations
(CF) were first normalized for each inflammatory mediator, so that
all mediator levels were converted into the same scale (from 0 to 1).
All measurements of a given inflammatory mediator from a single
animal were normalized as a group, by dividing each value by the
Euclidean norm of the group. In this way, any artifactual effects on
variance due to the different ranges of concentration observed for
different mediators were eliminated.
Hierarchical clustering
Fold change values were calculated by dividing the difference
between the later (x2) and earlier (x1) mediator values by the earlier
value: (x2-x1)/x1; we avoided division by 0 by replacing x1 with a
very small number (1025) when necessary. The columns of the
Figure 4. Dynamic Network Analysis (DyNA) of inflammatory mediators produced by normoxic and hypoxic mouse hepatocytes
isolated from MCP-12/2 mice. Primary hepatocytes isolated from MCP-12/2 mice were cultured under normoxic or hypoxic conditions (1–72 h)
followed by measurement of inflammatory mediators in both lysates and supernatants as described in the Materials and Methods. After data
normalization, DyNA was performed for both lysates and supernatants during each of the following five time frames: 1–3 h, 3–6 h, 6–24 h, 24–48 h,
and 48–72 h as indicated. Panels show a summary of the DyNAs representing the principal inflammatory mediator ‘‘nodes’’ for both normoxia (A)
and hypoxia (B) lysates and supernatants. (C) Stacked bars representing the total number of connections for each inflammatory mediator over all
time intervals.
doi:10.1371/journal.pone.0079804.g004
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dendrogram contained the mean of fold changes across all
animals. We employed several MatLabH functions to carry out
this analysis: linkage, with average link and Pearson correlation
distance, and cluster was used to find 2–4 clusters in both fold
change and raw data (mediator concentrations adjusted for protein
content vs. time, unaveraged, all animals included).
Principal Component Analysis and k-means clustering
Normalized inflammatory mediator data (each measurement
taken to be a single point in 18-dimensional inflammatory
mediator space) were transformed into principal component space
using the MatLabR function, princomp. We then examined
projections of inflammatory mediators into principal component
Figure 5. Time-dependent expression and release of IL-6 in mouse hepatocytes. Primary hepatocytes from wild-type (open symbols) and
MCP-12/2 (closed symbols) mice were cultured under normoxic (Panels A and B) and hypoxic (Panels C and D) conditions for 1, 3, 6, 24, 48 and 72 h
followed by measurement of IL-6 in both lysates and supernatants using the LuminexTM xMAP technology as described in the Materials and Methods.
Results are the mean 6 SEM (n= 4–8 independent experiments, analyzed by Two-way ANOVA, P,0.05 (wild-type vs. MCP-12/2) for all conditions
except hypoxia lysates, Panel C).
doi:10.1371/journal.pone.0079804.g005
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Figure 6. Differential expression of MCP-1 and IL-6 in wild-type and MCP-12/2 hepatocytes. Primary hepatocytes isolated from wild-type
and MCP-12/2 mice (n = 3 each) were cultured under normoxic and hypoxic conditions for 48 h in three independent experiments. The cells were
then fixed and processed for confocal immunofluorescence imaging as described in the Materials and Methods. (A) Fluorescent labeling: Phalloidin
(white), MCP-1 (red), IL-6 (green), Hoechst (blue). (B) Quantification of immunostained cells (fluorescence intensity from 600–700 hepatocytes from 3
independent fields, n = 3 coverslips/experiment). Results are the mean 6 SEM (*P,0.001 wild-type vs. MCP-12/2, analyzed by t-test).
doi:10.1371/journal.pone.0079804.g006
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space by using the score coefficients for the first 2, 3, or 4 principal
components. We employed k-means clustering using the MatLabH
function, kmeans, using as a distance metric the cosine of the angle
between a point and the origin. We computed clusters starting
with k = 2, 3, or 4 random centroids. At each level of k, we
repeated the clustering 10 times, resetting new centroids each time
and taking the lowest mean distance between points and their
nearest centroids as the best result.
Figure 7. Elevated plasma MCP-1 levels are associated with mortality and morbidity in human trauma/hemorrhage. (A) MCP-1 levels
in plasma samples from trauma patients (survivors vs. non-survivors, n = 15 each) taken within the first 24 h after trauma as described in the Materials
and Methods. Results represent the mean 6 SEM (The dotted line represents the mean value, *P=0.001, survivors vs. non-survivors analyzed by
Mann-Whitney U test). (B–C) Plot of IL-6 vs. MCP-1 levels in blood samples from normotensive (B) and hypotensive (C) trauma patients (n = 31 each)
taken within the first 24 h after trauma, followed by sampling at 48, 72 and 96 h as described in the Materials and Methods. (D–E) Grouping of T/HS
patients based on circulating MCP-1/CCL2 levels: Panel D shows MCP-1 values,1000 pg/ml (n = 38 patients) and Panel E shows values.1500 pg/ml
(n = 8 patients). Panel F shows the overall demographics (Age, ISS, total LOS, ICU LOS, and ventilation days) of T/HS patients segregated according to
plasma MCP-1 levels (,1000 pg/ml; [n = 38 patients] vs. .1500 pg/ml; [n = 8 patients]). Results represent the mean 6 SEM. (*P,0.05, analyzed by,
MCP-1,1000 pg/ml vs. MCP-1.1500 pg/ml).
doi:10.1371/journal.pone.0079804.g007
Figure 8. Plasma MCP-1 levels in blood samples from trauma patients. Plasma MCP-1 levels in blood samples from normotensive (Panel A)
and hypotensive (Panel B) trauma patients (n = 31 each as in Fig. 7 Panels B–C). Panel C shows the overall demographics of the normotensive
(n = 27) and hypotensive patients (n = 19) segregated according to plasma MCP-1 levels (,1000 pg/ml and.1500 pg/ml) and blood pressure status.
Results represent the mean 6 SEM.
doi:10.1371/journal.pone.0079804.g008
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Meta-clustering
The Adjusted Rand Index (ARI) was first calculated pairwise
between clustering results including 2, 3, or 4 principal compo-
nents, choosing the result that captured the most information with
the fewest principal components. We then used ARI to compare
hierarchical clustering results with k = 2, 3, and 4 to k-means
clustering results with k = 2, 3 and 4 in a pairwise manner. The
maximum Rand Index dictated the k of the hierarchical and k-
means clustering results that were moved forward into further
analysis. We compared PCA k-means clustering to each of fold
change hierarchical clustering and raw data hierarchical clustering
individually. The k was chosen for k-means clustering that
maximized both ARI values. We then filtered the results by
discarding inflammatory mediators that showed inconsistent
segregation patterns across the three analyses. The basis of
comparison across different experiments was a consensus cluster-
ing containing only the mediators for whose coordination patterns
we had confidence, as shown in detail in Figures S9, S10, S11,
S12, S13, S14, S15, S16. Briefly, a block of data was constructed
with one mediator in each row and its corresponding cluster label
for each of the three results in the columns using Microsoft ExcelH.
Sorting this block of data by each of the cluster label columns
successively allowed us to compare the memberships of clusters
across the three results and to identify corresponding clusters
between results. These were clusters that contained a common set
of mediators across all three results. We used the following
heuristic to determine consensus: once a cluster from one result
was associated with clusters from the other results, (e.g. Cluster A
from Raw Data was associated with Cluster 2 from Fold Change
and Cluster IV from PCA clustering) it could not be associated
with any other clusters. For example Cluster 1 could not associate
with both Cluster A and Cluster B. Mediators that did not
segregate into corresponding clusters across all results were
deemed inconsistent and omitted from the consensus clustering
result. This consensus outcome became the basis of comparison
among experimental conditions (see Figures S9, S10, S11, S12,
S13, S14, S15, S16).
Dynamic Network Analysis (DyNA)
Inflammatory mediator networks were created over time
periods between consecutive measurements (1–3 h, 3–6 h, 6–
24 h, 24–48 h, and 48–72 h) using MatlabH and InkscapeH
software (http://inkscape.org/). In order to be included in the
DyNA, a given mediator had to be statistically significantly
different from its baseline value (no treatment [time= 1 h];
P,0.05 by Student’s t-test). Connections in the network were
created if the correlation coefficient between two nodes (inflam-
matory mediators) was greater or equal to a threshold of 0.7 (based
on a total of 12 samples with 10 degrees of freedom, P,0.05).
Human trauma patient selection and analysis
All human sampling was done following approval by the
University of Pittsburgh Institutional Review Board and written
informed consent was obtained from each patient or next of kin as
per Institutional Review Board regulations. From a cohort of 493
blunt trauma patients admitted to Presbyterian University
Hospital (part of the University of Pittsburgh Medical Center),
we selected two cohorts of blunt trauma patients (all $18 years
old). Exclusion criteria included: life expectancy ,24 h, penetrat-
ing trauma only, and traumatic brain injury. The first cohort
included 30 trauma patients separated into two groups: 15
survivors (mean age: 60.563.7 years, range: 43–86 years, mean
ISS: 24.562.8, range: 9–50), and 15 non-survivors (mean age:
59.564.9 years, range: 25–86 years, mean ISS: 24.862.3, range:
10–38). The second cohort included 62 patients (all survivors)
separated into two groups matched on age, gender, and Injury
Severity Score (ISS): 31 normotensive patients (19 males and 12
females; systolic blood pressure .90 mmHg, mean age: 44.462.2
years, range: 24–75 years, mean ISS: 23.561.3, range: 10–38),
matched with 31 hypotensive patients (19 males and 12 females;
systolic blood pressure ,90 mmHg, duration of hypotension post-
injury: 861 h, range: 2–21 h, mean age: 45.163.4 years, range:
20–89 years, mean ISS: 23.562.2, range: 4–54). One to four
blood plasma samples per patient were collected within the first
24 h post-injury, followed by additional sampling at 48, 72, and
96 h. All blood samples were stored at 280uC until analysis.
MCP-1 and IL-6 were measured using the LuminexTM 100 IS
system and the Human 25-plexH LuminexTM beadset (BioSource,
now Invitrogen) or the MilliplexTM MAP kit (Millipore, Billerica,
MA).
Supporting Information
Figure S1 Relevant inflammatory mediator groupings
in the hepatocyte response to normoxia as determined
by consensus of clustering methods. Primary hepatocytes
from wild-type mice were cultured under normoxic (control,
21% O2) conditions for 1, 3, 6, 24, 48 and 72 h as described in the
Materials and Methods. At the end of the experiments, samples from
lysates (L) and supernatants (SN, see Fig. S3 below) were assayed
for 18 mouse inflammatory mediators using the Luminex xMAP
technology, the measurements were normalized for protein
content and over each inflammatory mediator and each sample
and k-means clustering was performed over dynamic inflamma-
tory mediator measurements from 4 experimental conditions (N
vs. H, and L vs. SN) using MatLabH software as described in the
Materials and Methods. The tridimensional grouping of significant
inflammatory mediators according to k-means clustering is
represented and the percentage of total variance corresponding
to the analysis is shown on the top of the graph.
(TIF)
Figure S2 Relevant inflammatory mediator groupings
in the hepatocyte response to hypoxia as determined by
consensus of clustering methods. Primary hepatocytes from
wild-type mice were cultured under hypoxic (1% O2) conditions
for 1, 3, 6, 24, 48 and 72 h as described in the Materials and
Methods. At the end of the experiments, samples from both lysates
(L) and supernatants (SN, see Fig. S4 below) were assayed for 18
mouse inflammatory mediators using the Luminex xMAP
technology, the measurements were normalized for protein
content and over each inflammatory mediator and each sample
and k-means clustering was performed over dynamic inflamma-
tory mediator measurements from 4 experimental conditions (N
vs. H, and L vs. SN) using MatLabH software as described in the
Materials and Methods. The tridimensional grouping of significant
inflammatory mediators according to k-means clustering is
represented and the percentage of total variance corresponding
to the analysis is shown on the top of the graph.
(TIF)
Figure S3 Relevant inflammatory mediator groupings
in the hepatocyte response to normoxia as determined
by consensus of clustering methods: wild-type superna-
tant. (See legend of Figure S1 for detailed description).
(TIF)
Figure S4 Relevant inflammatory mediator groupings
in the hepatocyte response to hypoxia as determined by
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consensus of clustering methods: wild-type supernatant.
(See legend of Figure S2 for detailed description)
(TIF)
Figure S5 Relevant inflammatory mediator groupings
in the hepatocyte response to normoxia as determined
by consensus of clustering methods. Primary hepatocytes
from MCP-12/2 mice were cultured under normoxic (control,
21% O2) conditions for 1, 3, 6, 24, 48 and 72 h as described in the
Materials and Methods. At the end of the experiments, samples from
both lysates (L) and supernatants (SN, see Fig. S7 below) were
assayed for 18 mouse inflammatory mediators using the Luminex
xMAP technology, the measurements were normalized for protein
content and over each inflammatory mediator and each sample
and k-means clustering was performed over dynamic inflamma-
tory mediator measurements from 4 experimental conditions (N
vs. H, and L vs. SN) using MatLabH software as described in the
Materials and Methods. The tridimensional grouping of significant
inflammatory mediators according to k-means clustering is
represented and the percentage of total variance corresponding
to each analysis is shown on the top of the graph.
(TIF)
Figure S6 Relevant inflammatory mediator groupings
in the hepatocyte response to hypoxia as determined by
consensus of clustering methods. Primary hepatocytes from
MCP-12/2 mice were cultured under hypoxic (1% O2)
conditions for 1, 3, 6, 24, 48 and 72 h as described in the
Materials and Methods. At the end of the experiments, samples from
both lysates (L) and supernatants (SN, see Fig. S8 below) were
assayed for 18 mouse inflammatory mediators using the Luminex
xMAP technology, the measurements were normalized for protein
content and over each inflammatory mediator and each sample
and k-means clustering was performed over dynamic inflamma-
tory mediator measurements from 4 experimental conditions (N
vs. H, and L vs. SN) using MatLabH software as described in the
Materials and Methods. The tridimensional grouping of significant
inflammatory mediators according to k-means clustering is
represented and the percentage of total variance corresponding
to each analysis is shown on the top of the graph.
(TIF)
Figure S7 Relevant inflammatory mediator groupings
in the hepatocyte response to normoxia as determined
by consensus of clustering methods: MCP-12/2 super-
natant. (See legend of Figure S5 for detailed description).
(TIF)
Figure S8 Relevant inflammatory mediator groupings
in the hepatocyte response to hypoxia as determined by
consensus of clustering methods: MCP-12/2 superna-
tant. (See legend of Figure S6 for detailed description).
(TIF)
Figure S9 Meta-clustering process: from three indepen-
dent clustering results to a consensus clustering. Each
method is colored one hue (blue = hierarchical clustering of raw
data, orange =hierarchical clustering on fold changes, green= k-
means clustering in PCA space). Clusters within each method are
demarcated by shades and tones of each hue (Step 1). Each
column was sorted alphabetically by mediator name (Step 2), and
the clustering results were combined into a single matrix (Step 3).
The rows of this matrix were sorted by cluster labels, for each
method sequentially (Step 4). This sorting allowed visual
identification of clusters that were associated across methods.
From here, a consensus (Step 6) was determined by identifying
associated clusters and removing inconsistent mediators (Step 5)
that fell outside of the associated clusters. Associated clusters are
those that contain the same mediators across all three clustering
methods. If two or more clusters from one method were associated
with one cluster from each of the other methods, they were
considered to be part of the same cluster, provided neither cluster
was associated with any other clusters. Analysis for normoxia
supernatants (wild-type): In Step 4 for this matrix, the rows
were first sorted according to fold change cluster labels (orange),
then by raw data cluster labels (blue), and finally by PCA clusters
(green). In Step 5, all mediators from Cluster A (light blue) were
also found in Cluster 2 (bright orange) and Cluster IV (dark green).
Likewise, all mediators from Cluster 1 (light orange) were found in
Clusters B (bright blue) and II (light green). Members of those
clusters that were not found in Cluster 1 were discarded.
(TIF)
Figure S10 Meta-clustering analysis (see legend of Fig.
S9) for hypoxia supernatants (wild-type): In Step 4 for
this matrix, the rows were first sorted according to raw
data cluster labels (blue), then by fold change cluster
labels (orange), and finally by PCA clusters (green). In
Step 5, all mediators from Cluster D (dark blue) were also found in
Cluster 2 (bright orange) and Cluster II (light green) and therefore,
these three clusters were considered to be the same. Any mediators
associated with Cluster II, but not with both Cluster 2 and Cluster
D were then marked as inconsistent and discarded from the
analysis. Clusters I (grey), III (medium green), and IV (dark green)
were all associated with Cluster B (bright blue) and Cluster 2
(bright orange).
(TIF)
Figure S11 Meta-clustering analysis (see legend of Fig.
S9) for normoxia lysates (wild-type): In Step 4 for this
matrix, the rows were first sorted according to fold
change cluster labels (orange), then by raw data cluster
labels (blue), and finally by PCA clusters (green). In Step
5, all mediators from Cluster C (medium blue) were also found in
Cluster 1 (light orange) and Cluster I (grey) and therefore, these
three clusters were considered to be the same. Any mediators
associated with Cluster C, but not with both Cluster 1 and Cluster
I were then marked as inconsistent and discarded from the
analysis. Clusters B (bright blue) and D (dark blue) were both
associated with Cluster II (light green) and Cluster 2 (bright
orange).
(TIF)
Figure S12 Meta-clustering analysis (see legend of Fig.
S9) for hypoxia lysates (wild-type): In Step 4 for this
matrix, the rows were first sorted according to fold
change cluster labels (orange), then by raw data cluster
labels (blue), and finally by PCA clusters (green). In Step
5, most mediators from Cluster A (light blue) were also found in
Cluster 2 (medium orange) and Cluster I (grey) and therefore,
these three clusters were considered to be the same. Any mediators
associated with Cluster A, but not with both Cluster 2 and Cluster
I were then marked as inconsistent and discarded from the
analysis. Clusters C (medium blue) and D (dark blue) were both
associated with Cluster 4 (dark orange) and Cluster III (medium
green).
(TIF)
Figure S13 Meta-clustering analysis (see legend of Fig.
S9) for normoxia supernatants (MCP-12/2): In Step 4 for
this matrix, the rows were first sorted according to fold
change cluster labels (orange), then by raw data cluster
labels (blue), and finally by PCA clusters (green). In Step
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5, a majority of mediators from Cluster II (light green) were also
found in Cluster B (bright blue) and Cluster 1 (light orange) and
therefore, these three clusters were considered to be the same. Any
mediators associated with Cluster II, but not with both Cluster B
and Cluster 1 were marked as inconsistent and discarded from the
analysis. Likewise, Clusters D (dark blue), 2 (bright orange), and III
(medium green) were associated.
(TIF)
Figure S14 Meta-clustering analysis (see legend of Fig.
S9) for hypoxia supernatants (MCP-12/2): In Step 4 for
this matrix, the rows were first sorted according to fold
change cluster labels (orange), then by raw data cluster
labels (blue), and finally by PCA clusters (green). In Step
5, all mediators from Cluster A (light blue) were also found in
Cluster 2 (bright orange) and Cluster III (medium green) and
therefore, these three clusters were considered to be the same. Any
mediators associated with Cluster A, but not with both Cluster 2
and Cluster III were marked as inconsistent and discarded from
the analysis.
(TIF)
Figure S15 Meta-clustering analysis (see legend of Fig.
S9) for normoxia lysates (MCP-12/2): In Step 4 for this
matrix, the rows were first sorted according to fold
change cluster labels (orange), then by raw data cluster
labels (blue), and finally by PCA clusters (green). In Step
5, all mediators from Cluster 1 (light orange) were also found in
Cluster B (bright blue) and Cluster II (light green) and therefore,
these three clusters were considered to be the same. Any mediators
associated with Cluster 1, but not with both Cluster B and Cluster II
were marked as inconsistent and discarded from the analysis.
Clusters III (medium green) and IV (dark green) were both
associated with Cluster B (bright blue) and Cluster 2 (bright orange).
(TIF)
Figure S16 Meta-clustering analysis (see legend of Fig.
S9) for hypoxia lysates (MCP-12/2): In Step 4 for this
matrix, the rows were first sorted according to raw data
cluster labels (blue), then by fold change cluster labels
(orange), and finally by PCA clusters (green). In Step 5, all
mediators from Cluster B (medium blue) were also found in
Cluster 3 (bright orange) and Cluster III (medium green) and
therefore, these three clusters were considered to be the same. Any
mediators associated with Cluster B, but not with both Cluster 3
and Cluster III were marked as inconsistent and discarded from
the analysis. Clusters I (grey), II (light green), and IV (dark green)
were all associated with Cluster A (light blue) and Cluster 1 (light
orange).
(TIF)
Figure S17 Dynamic Network Analysis (DyNA) of in-
flammatory mediators produced by normoxic and
hypoxic mouse hepatocytes. Primary hepatocytes from
wild-type mice were cultured under normoxic or hypoxic
conditions (1–72 h) followed by measurement of cytokines/
chemokines in both lysates and supernatants and lysates as
described in the Materials and Methods. Gray boxes indicate that the
mediator is statistically significantly different from its baseline
value (no treatment [time= 1 h]; P,0.05) and the digits represent
the number of connections resulting from the DyNAs during each
of the following five time frames: 1–3 h, 3–6 h, 6–24 h, 24–48 h,
and 48–72 h for both lysates and supernatants.
(TIF)
Figure S18 Dynamic Network Analysis (DyNA) of in-
flammatory mediators produced by normoxic and
hypoxic mouse hepatocytes from MCP-12/2 mice.
Primary hepatocytes from MCP-12/2 mice were cultured under
normoxic or hypoxic conditions (1–72 h) followed by measure-
ment of cytokines/chemokines in both lysates and supernatants
and lysates as described in the Materials and Methods. Gray boxes
indicate that the mediator is statistically significantly different from
its baseline value (no treatment [time= 1 h]; P,0.05) and the
digits represent the number of connections resulting from the
DyNAs during each of the following five time frames: 1–3 h, 3–
6 h, 6–24 h, 24–48 h, and 48–72 h for both lysates and
supernatants.
(TIF)
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